Parabilis Medicines, Inc. (PBLS)
38.30
-0.71
(-1.82%)
USD |
NASDAQ |
Sep 01, 14:04
Parabilis Medicines Cash from Operations (TTM) : -118.07M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -118.07M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Kailera Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |